日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

疫苗诱导的免疫性血栓性血小板减少症治疗的抗血栓疗效和出血风险

Leung, Halina H L; Ahmadi, Zohra; Lee, Brendan; Casey, John; Ratnasingam, Sumita; McKenzie, Steven E; Perdomo, Jose; Chong, Beng H

NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia

疫苗诱导的免疫性血栓性血小板减少症中的NETosis和血栓形成

Halina H L Leung # ,Jose Perdomo # ,Zohra Ahmadi ,Shiying S Zheng ,Fairooj N Rashid ,Anoop Enjeti ,Stephen B Ting ,James J H Chong ,Beng H Chong

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

关于原发性免疫性血小板减少症的调查和管理的最新国际共识报告

Provan, Drew; Arnold, Donald M; Bussel, James B; Chong, Beng H; Cooper, Nichola; Gernsheimer, Terry; Ghanima, Waleed; Godeau, Bertrand; González-López, Tomás José; Grainger, John; Hou, Ming; Kruse, Caroline; McDonald, Vickie; Michel, Marc; Newland, Adrian C; Pavord, Sue; Rodeghiero, Francesco; Scully, Marie; Tomiyama, Yoshiaki; Wong, Raymond S; Zaja, Francesco; Kuter, David J

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies

罗米司亭用于治疗新诊断或持续性免疫性血小板减少症 (ITP) 成人患者(治疗时间不超过 1 年)以及慢性 ITP 患者(治疗时间超过 1 年):一项基于已完成的罗米司亭研究的综合数据的亚组分析

Kuter, David J; Newland, Adrian; Chong, Beng H; Rodeghiero, Francesco; Romero, Monica T; Pabinger, Ingrid; Chen, Yuqi; Wang, Kejia; Mehta, Bhakti; Eisen, Melissa

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

美国血液学会 2018 年静脉血栓栓塞症管理指南:肝素诱导的血小板减少症

Cuker, Adam; Arepally, Gowthami M; Chong, Beng H; Cines, Douglas B; Greinacher, Andreas; Gruel, Yves; Linkins, Lori A; Rodner, Stephen B; Selleng, Sixten; Warkentin, Theodore E; Wex, Ashleigh; Mustafa, Reem A; Morgan, Rebecca L; Santesso, Nancy

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

罗米司亭在脾切除和未脾切除的原发性免疫性血小板减少症患者中的安全性和有效性

Cines, Douglas B; Wasser, Jeffrey; Rodeghiero, Francesco; Chong, Beng H; Steurer, Michael; Provan, Drew; Lyons, Roger; Garcia-Chavez, Jaime; Carpenter, Nancy; Wang, Xuena; Eisen, Melissa

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

接受罗米司亭治疗原发性免疫性血小板减少症相关血小板减少症的成年患者骨髓形态学的变化

Janssens, Ann; Rodeghiero, Francesco; Anderson, David; Chong, Beng H; Boda, Zoltán; Pabinger, Ingrid; Červinek, Libor; Terrell, Deirdra R; Wang, Xuena; Franklin, Janet

Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro

免疫性血小板减少症:抗血小板自身抗体抑制巨核细胞生成前血小板,并损害体外血小板生成。

Iraqi, Muna; Perdomo, Jose; Yan, Feng; Choi, Philip Y-I; Chong, Beng H

Heme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in mice

小鼠血红素加氧酶-1缺乏症会改变红细胞岛的形成、稳态红细胞生成和红细胞寿命。

Fraser, Stuart T; Midwinter, Robyn G; Coupland, Lucy A; Kong, Stephanie; Berger, Birgit S; Yeo, Jia Hao; Andrade, Osvaldo Cooley; Cromer, Deborah; Suarna, Cacang; Lam, Magda; Maghzal, Ghassan J; Chong, Beng H; Parish, Christopher R; Stocker, Roland

Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts.

α-突触核蛋白在人类星形胶质细胞、皮层神经元和成纤维细胞中的摄取和线粒体功能障碍

Braidy Nady, Gai Wei-Ping, Xu Ying Hua, Sachdev Perminder, Guillemin Gilles J, Jiang Xing-Mai, Ballard J William O, Horan Martin P, Fang Zhi Ming, Chong Beng H, Chan Daniel Kam Yin